Anixa Inks Joint Development Agreement With Cleveland Clinic To Develop Novel Cancer Vaccines

RTTNews | hace 503
Anixa Inks Joint Development Agreement With Cleveland Clinic To Develop Novel Cancer Vaccines

(RTTNews) - Biotechnology company Anixa Biosciences, Inc. (ANIX) announced Wednesday that it has entered into a joint development agreement with Cleveland Clinic to develop novel vaccines for various cancer types.

Anixa currently collaborates with Cleveland Clinic on breast cancer and ovarian cancer vaccines

Cleveland Clinic is currently conducting a Phase 1 clinical trial targeting triple negative breast cancer (TNBC), the most aggressive and lethal form of breast cancer, and an ovarian cancer vaccine is in pre-clinical development in collaboration with the National Cancer Institute.

The vaccines focus on a novel scientific mechanism never used before in a cancer vaccine. The vaccines were developed at Cleveland Clinic and licensed to Anixa Biosciences. Cleveland Clinic is entitled to royalties and other commercialization revenues from the Company.

The research under this new JDA will be led at Cleveland Clinic by Thaddeus Stappenbeck, Department Chair of Inflammation and Immunity, and will include Justin Johnson, one of the co-inventors of the breast and ovarian cancer vaccines along with the late Vincent Tuohy.

read more
Rally May Stall For Malaysia Stock Market

Rally May Stall For Malaysia Stock Market

The Malaysia stock market has ticked higher in two straight sessions, collecting more than 5 points or 0.3 percent along the way. The Kuala Lumpur Composite Index now sits just above the 1,600-point plateau although it may run out of steam on Wednesday.
RTTNews | hace 11 minutos
Renewed Selling Pressure Likely For Japan Stock Market

Renewed Selling Pressure Likely For Japan Stock Market

Ahead of Tuesday's holiday for the Autumnal Equinox, the Japanese stock market had alternated between positive and negative finishes through the previous four trading days, since the end of the four-day winning streak in which it had surged more than 1,430 points or 3.2 percent. The Nikkei 225 now sits just beneath the 45,500-point plateau and it's looking at a soft start on Wednesday.
RTTNews | hace 26 minutos
KOSPI Due For Profit Taking On Wednesday

KOSPI Due For Profit Taking On Wednesday

The South Korea stock market has finished higher in back-to-back sessions, advancing more than 40 points or 1.1 percent along the way. Now at another fresh record closing high, the KOSPI sits just above the 3,485-point plateau although investors are likely to lock in gains on Wednesday.
RTTNews | hace 41 minutos
Consumer Confidence Ebbs In September - BoK

Consumer Confidence Ebbs In September - BoK

Consumer confidence in South Korea dipped in September, the latest survey from the Bank of Korea said on Wednesday with a consumer sentiment index score of 110.1.
RTTNews | hace 59 minutos
Japan Manufacturing PMI Data Due On Wednesday

Japan Manufacturing PMI Data Due On Wednesday

Japan will on Wednesday see September results for the manufacturing and services PMIs from Jibun Bank, highlighting a light day for Asia-Pacific economic activity. In August, their scores were 49.7 and 53.1, respectively.
RTTNews | hace 1h 41min
OECD Warns Full Effects Of High U.S. Tariffs Yet To Be Felt

OECD Warns Full Effects Of High U.S. Tariffs Yet To Be Felt

The Organisation for Economic Co-operation and Development said in a report on Tuesday that the full impact of the massive hike in trade tariffs announced by the U.S. is yet to be felt though early effects are becoming increasingly evident.
RTTNews | hace 2h 58min
TSX Retreats After Sailing Past 30k Mark For First Ever Time

TSX Retreats After Sailing Past 30k Mark For First Ever Time

Canadian benchmark S&P/TSX Composite Index breached the 30k mark for the first ever time, and moved on to a new high Tuesday morning before paring gains and slipping into negative territory, due largely to profit taking.
RTTNews | hace 5h 24min